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Abstract
Background
Evidence on the impact of expectancy on acupuncture treatment response is conflicting.
Objectives
This secondary analysis of a randomized sham-controlled trial on acupuncture for meno-
pausal hot flashes investigated whether treatment expectancy score was associated with
hot flash score at end-of-treatment. Secondary analyses investigated whether there were
associations between other pre-specified factors and hot flash score.
Study design
Women experiencing moderately-severe hot flashes were randomized to receive 10 ses-
sions of real or sham acupuncture over eight weeks. Hot flash score was collected using a
seven-day hot flash diary, and expectancy using the modified Credibility and Expectancy
Questionnaire immediately after the first treatment. Linear mixed-effects models with ran-
dom intercepts were used to identify associations between expectancy score and hot flash
score at end-of-treatment. Regression was also used to identify associations between pre-
specified factors of interest and hot flash score. Because there was no difference between
real and sham acupuncture for the primary outcome of hot flash score, both arms were com-
bined in the analysis.
Results
285 women returned the Credibility and Expectancy Questionnaire, and 283 women com-
pleted both expectancy measures. We found no evidence for an association between ex-
pectancy and hot flash score at end-of-treatment for individual cases in either acupuncture
PLOS ONE | https://doi.org/10.1371/journal.pone.0186966 October 27, 2017 1 / 13
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPENACCESS
Citation: Ee CC, Thuraisingam S, Pirotta MV,
French SD, Xue CC, Teede HJ (2017) Expectancy
after the first treatment and response to
acupuncture for menopausal hot flashes. PLoS
ONE 12(10): e0186966. https://doi.org/10.1371/
journal.pone.0186966
Editor: Stephen L. Atkin, Weill Cornell Medical
College Qatar, QATAR
Received: January 24, 2017
Accepted: October 11, 2017
Published: October 27, 2017
Copyright: © 2017 Ee et al. This is an open access
article distributed under the terms of the Creative
Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in
any medium, provided the original author and
source are credited.
Data Availability Statement: Data are included in
Supporting Information files.
Funding: CE was supported by an NHMRC
Postgraduate Scholarship, HT by an NHMRC
Practitioner Fellowship, MP by an NHMRC Career
Development Fellowship. The main study was
funded by a Project Grant 1004006 from the
National Health and Medical Research Council,
Australia (www.nhmrc.gov.au). SDF is supported
by a Canadian Chiropractic Research Foundation
Professorship. The funders had no role in study
or sham group. Hot flash scores at end-of-treatment were 8.1 (95%CI, 3.0 to 13.2; P =
0.002) points lower in regular smokers compared to those who had never smoked, equiva-
lent to four fewer moderate hot flashes a day.
Conclusion
In our study of acupuncture for menopausal hot flashes, higher expectancy after the first
treatment did not predict better treatment outcomes. Future research may focus on other
determinants of outcomes in acupuncture such as therapist attention. The relationship
between smoking and hot flashes is poorly understood and needs further exploration.
Introduction
Acupuncture is a Chinese medical intervention that involves the insertion of fine metal needles
into specified areas of the body. Several large meta-analyses of acupuncture for painful condi-
tions have demonstrated that acupuncture produces small specific effects and considerable
non-specific effects [1–3]. Critics of acupuncture assert that its clinical response is by and large
due to high expectations of the patients[4]. However, the empirical evidence for or against the
influence of expectancy on acupuncture treatment outcome is contradictory.
Expectancy, or its synonym expectations, refers to an individual’s beliefs about future
events[5]. Treatment expectancy can have a positive or negative impact on treatment outcome
and is a major contributor to the placebo response[6]. Expectations may vary according to
individual understanding about the illness, treatment, and experiences with past treatments,
and may change over the course of treatment [5].
Two systematic reviews of acupuncture trials that measured the impact of participants’
expectations on outcomes have reported mixed findings. Colagiuri and Smith reviewed find-
ings from nine acupuncture trials[7], of which the majority examined acupuncture for painful
conditions and used mainly self-reported outcomes. Four trials failed to find any effects of
expectancy on outcomes, while five found at least some evidence that higher expectancy pre-
dicted better outcomes. Prady et al reviewed 58 trials, similarly most on painful conditions,
and again found conflicting evidence[8]. In more recent research, Vase and colleagues demon-
strated that perceived treatment allocation (to real or sham acupuncture) resulted in signifi-
cantly lower dental pain levels[9], and Bauml and colleagues reported that higher expectancy
predicted higher treatment response for sham but not for real electro-acupuncture in a trial of
acupuncture for joint pain in breast cancer patients[10]. There is limited evidence on the
impact of expectancy on acupuncture treatment outcomes for conditions other than pain.
Hot flashes (HFs) cause significant morbidity in menopausal women[11, 12] and last an
average of five years[13]. Because of perceived shortcomings of conventional medical treat-
ment, complementary therapies for hot flashes have increased in popularity[14] and are used
by up to 80% of women during the menopause[15]. Acupuncture is a popular treatment
amongst menopausal women[16] however there is insufficient evidence of its efficacy as a
treatment for hot flashes[17]. We conducted a randomized sham-controlled trial testing the
efficacy of acupuncture for hot flashes[18]. As both real and sham acupuncture groups
improved equally in our study, we now aim to examine the impact of treatment expectancy on
the acupuncture response. The primary aim of this post hoc analysis was to investigate whether
treatment expectancy score (measured at the end of the first acupuncture treatment) was
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associated with HF score at end-of-treatment.The secondary aims were to determine other fac-
tors associated with hot flash score at end-of-treatment.
Materials and methods
This is an a priori planned secondary analysis of data from a randomized controlled trial
(RCT) that investigated the effects of acupuncture compared to sham on menopausal hot
flashes. The protocol[19] and key findings[18] from the RCT have been published. Ethics
approval was obtained from the Human Research Ethics Committee, University of Melbourne
and the trial was prospectively registered on the Australian and New Zealand Clinical Trial
Registry http://www.anzctr.org.au (ACTRN12611000393954).
Participants
We recruited 327 women having at least seven moderately-severe HFs a day from the commu-
nity, in metropolitan and regional areas of Australia. Participants were aged over 40 years old
and were postmenopausal or in the late menopausal transition. Exclusion criteria included
current use of menopausal hormone therapy, other HF treatments within the preceding 12
weeks, bilateral salpingo-oophorectomy, breast cancer, and needle acupuncture within the last
two years.
Intervention and control
Women were randomized to receive real acupuncture (based on Chinese Medicine principles)
or non-invasive sham acupuncture. Ten treatments were given over eight weeks, twice weekly
for the first fortnight and weekly thereafter. Participants were blinded to treatment allocation,
but acupuncturists were not.
Outcomes
The trial primary outcome was change in HF score at end-of-treatment. HF frequency, severity
and a composite HF score were calculated from validated seven-day HF diaries[20] collected
at baseline, four weeks, end-of-treatment (eight weeks), and three- and six-month after end of
treatment. At baseline, we collected information on known risk factors for HFs. From these,
we selected variables that we hypothesised were most likely to influence hot flash score at end-
of-treatment. We did not include variables with a significant proportion of missing data (such
as income) or little variation between categories (such as ethnicity). The chosen variables are
summarised in Table 1.
Table 1. Information about potential confounders, collected at baseline.
Potential confounder Categories
Current smoking status
[21]
Never smoked, used to smoke, now smoke occasionally, or now smoke
regularly
Education level[22–24] Highest level of education attained (primary school, high school, college/
vocational training/university degree, or postgraduate);
Duration of hot flashes in
years
Anxiety score[25] Anxiety subscore from Hospital Anxiety and Depression Scale
Perceived treatment
allocation
Real/placebo/not sure
Practitioner gender[26] Male/female practitioner
Credibility score[27] 9 point Likert scale: 1 = “not at all useful”; 9 = “very useful”
https://doi.org/10.1371/journal.pone.0186966.t001
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Expectancy
We used a modified version of the Credibility and Expectancy Questionnaire (CEQ) to measure
expectancy. The CEQ is a validated, widely-used, quick and easy-to-administer 6-item scale for
measuring treatment expectancy and rationale credibility in clinical outcome studies[27]. We
administered this questionnaire immediately after the first treatment in order to capture expec-
tancy levels following the experience of a treatment but before expectations are influenced by
clinical improvement. Treating acupuncturists gave the participant a questionnaire to complete
at the end of the first treatment and then returned the questionnaires to us by reply-paid mail.
The CEQ consists of two sections: the first asks participants what they think will happen at
the end of treatment, and the second asks what they feel will happen. This distinguishes
between cognitive and affective aspects of belief, which can be distinct; one can hold rational
thoughts which conflict with a sense of hope or faith[27]. The first section contains four ques-
tions, three on credibility (logicalness of the treatment, success in reducing symptoms, confi-
dence in recommending to a friend) and one expectancy question (improvement in symptoms
by the end of treatment). The second section asks one credibility question (success of treat-
ment) and one expectancy question (improvement in symptoms) but distinguishes these as
how the patient feels about improvement rather than thinks. The original CEQ used a Likert
scale from 1–9, 1 representing “not at all” and 9 representing “very much” or “very useful” for
the credibility questions, and a scale from 0–100% in 10% increments for the expectancy ques-
tions. The midpoint was described as “somewhat useful”. To simplify the questionnaire we
applied the same 9-point Likert scale to the expectancy questions. A composite score was
derived for the four credibility questions, and for this analysis we calcuated mean scores for
each of the two expectancy questions.
As surveys to measure the success of blinding may enhance participants focus on this, we
measured this aspect immediately after the first treatment[28], by inserting a question at the
end of the CEQ which asked women to indicate which treatment they believed they had
received, with answer options of “real acupuncture”, “sham acupuncture” and “not sure”.
As all outcomes were self-assessed, outcome assessment was considered blinded as well.
Analysis
Analysis was restricted to the 285 women who provided CEQ data. The two expectancy items
(“Expectancy 1 and 2”) were included in the analysis and the wording of these questions is pre-
sented in Table 2.
Stata version 13.1 (StataCorp) was used for all analyses. Since the previous study did not
find a difference in outcome between the treatment groups, study arm was not included as a
confounder in this analysis. Instead, data for both arms were combined and analysed as one.
Bivariate analyses were performed to identify associations between independent variables and
hot flash score at end of treatment with adjustment for baseline hot flash score. The indepen-
dent variables tested were expectancy, HF duration (years), baseline anxiety, practitioner gen-
der, perceived treatment allocation, smoking status, credibility and education. The final model
Table 2. Wording of expectancy questions in the Credibility Expectancy Questionnaire.
Question Range
“Expectancy 1”: By the end of the treatment period, how much improvement in
your hot flashes do you think will occur?
1 = None at all
9 = Total
improvement
“Expectancy 2”: By the end of the treatment period, how much improvement in
your hot flashes do you really feel will occur?
1 = Not at all
9 = Very much
https://doi.org/10.1371/journal.pone.0186966.t002
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consisted of all variables found to be statistically significant in the bivariate analyses and the
multivariable analyses at the 0.05 alpha significance level. Both a log and square root transfor-
mation of the outcome variable were considered to minimise heteroscedasticity.
All models in the analyses were linear mixed-effects models with random intercepts.
Restricted maximum likelihood estimation (REML) was used to estimate the effect of expec-
tancy score and the other independent variables on hot flash score. These estimates, with 95%
confidence intervals and p-values, were reported. Missing data was assumed to be missing at
random in these analyses.
The goodness of fit of the models was assessed using residual plots (results not shown) and
the impact of potential outliers on regression results explored. No imputation methods were
carried out, however, a pattern-mixture model was used to evaluate the impact of the assump-
tion of missing at random (see S1 Fig).
Results
285 women returned the CEQ, and 283 completed both expectancy questions. Table 3
describes the demographic details of the participants. Participants were mainly Caucasian, well
educated and had good to excellent self-rated health levels. The mean age was 55 years. No
serious adverse events were reported. Fig 1 depicts the flow of participants in the study through
to end of treatment (eight weeks).
We found no evidence of an association between expectancy after the first treatment and
HF score at the end of the treatment period. On average, HF scores at end of treatment were
8.1 (95%CI, 3.0 to 13.2; P = 0.002) points lower in regular smokers compared to those who had
never smoked. There was a lack of evidence to suggest an association between the other inde-
pendent variables and HF score at end of treatment. Table 4 summarises the findings from the
bivariate analyses of the independent variables and HF score.
There were a few participants with large HF scores. These were found to have little influ-
ence on the regression model. A log or square root transformation of the outcome variable did
not seem to significantly reduce heteroscedasticity or change study conclusions.
Table 3. Participant baseline demographic characteristics.
N = 285 Missing
Characteristic n (%) n (%)
Age (years) 54.9 (4.1)* 37 (13.0)
Ethnicity 39 (13.7)
Caucasian 237 (96.3)
Non-Caucasian 9 (3.7)
Highest educational attainment 38 (13.3)
Primary or high school 93 (37.7)
Vocational training, diploma, university degree or higher 154 (62.4)
Average weekly household income 89 (31.2)
Low income ($0–599) 76 (38.8)
Middle income ($600–2000) 111 (56.6)
High income ($2000) 9 (4.6)
Self-rated health 39 (13.7)
Excellent 47 (19.1)
Very good 111 (45.1)
Good 73 (29.7)
Fair 11 (4.5)
Poor 4 (1.6)
https://doi.org/10.1371/journal.pone.0186966.t003
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The sensitivity analysis for missing data (S1 Fig) showed that mean hot flash scores would
be no different between regular and never smokers if regular smokers with missing data had a
mean hot flash score 10 points greater than the observed regular smokers. This difference is
larger than the standard deviation of hot flash scores for regular smokers and seems
implausible.
Discussion
In this post hoc analysis of a randomized sham-controlled trial of acupuncture for menopausal
hot flashes, we did not find evidence that higher expectations, perceived treatment allocation
or credibility score after the first treatment predicted a better treatment response to acupunc-
ture. Each one-point increase in expectancy score resulted in an estimated reduction of one
third of a mild hot flash per day, which is not clinically significant.
In previous trials of acupuncture for hot flashes, there is limited and inconclusive evidence
on the impact of expectancy on outcomes. In one large pragmatic trial comparing acupuncture
with usual care, positive expectations were not associated with treatment outcome[29]. In
Fig 1. Flowchart of trial procedures.
https://doi.org/10.1371/journal.pone.0186966.g001
Table 4. Bivariate associations between independent variables and hot flash score at EOT adjusted by baseline hot flash score (N = 285).
Independent Variables n* Missing n (%) Mean change in hot
flash score at EOT*
P-value
Expectancy question 1 (1–9) 6.8 (1.6)** 1 (0.4) -0.3 (-1.1 to 0.4) 0.42
Expectancy question 2 (1–9) 6.9 (1.7)** 2 (0.7) -0.3 (-1.0 to 0.4) 0.35
Credibility score (composite) (1–9) 6.8 (1.5)** - 0.02 (-0.8 to 0.8) 0.97
Hot flash duration (years) 5.1 (4.6)** 40 (14.0) 0.1 (-0.16 to 0.38) 0.42
Anxiety score 7.6 (4.2)** 35 (12.3) -0.2 (-0.5 to 0.1) 0.30
Practitioner gender 9 (3.2) 0.96
Female practitioners 98 -
Male practitioners compared to female practitioners 178 0.03 (-1.3 to 1.4)
Perceived study arm allocation 5 (1.8) 0.89
“Sham acupuncture” 13 -
“Real acupuncture” compared to “sham acupuncture” 91 -1.3 (-6.7 to 4.1)
“Not sure” compared to “sham acupuncture” 176 -1.0 (-6.3 to 4.3)
Smoking status 37 (13.0) 0.02
Never smoker 116 -
Regular smoker compared to never smoker 21 -8.1 (-13.2 to -3.0)
Occasional smoker compared to never smoker 8 -0.9 (-7.7 to 5.8)
Previously smoked compared to never smoked 103 -0.7 (-3.3 to 2.0)
Education 38 (13.3) 0.61
Completed primary school or high school 93 -
Completed a degree compared with primary school/high school 109 -1.4 (-4.3 to 1.4)
Completed postgraduate education compared with primary school/high
school
45 -1.00 (-4.6 to 2.6)
*number of participants with a HF score and response for the independent variable listed. There were 37 (13%) participants with missing HF score at end of
treatment.
**Mean (SD)
EOT = end of treatment
https://doi.org/10.1371/journal.pone.0186966.t004
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contrast, high expectancy predicted a greater response to treatment in the acupuncture group
in another open-labelled trial[30]. Meanwhile, participants in the real acupuncture group in a
sham-controlled pilot study had higher expectations than in the sham group but it is unclear if
this resulted in better outcomes[31]. Taken together, there is little evidence for an association
between expectancy and improvement in HFs in acupuncture trials, particularly in Western
countries.
The only variable that predicted treatment outcome in our study was smoking status. Being
a current smoker was associated with a clinically significant difference equivalent to four fewer
moderate hot flashes a day, when comparing never smokers with regular smokers, and is con-
sistent with a recent finding of the association between smoking status and a higher placebo
response in a trial of a pharmaceutical for hot flashes[21]. However, this was not mediated by
expectancy levels in our study. The reasons for this association are unclear. Smoking is a risk
factor for experiencing HFs[24, 32] and smokers tend to over-report the frequency of their hot
flashes[33], rate their hot flashes as more problematic[34] and report higher levels of bother
from their hot flashes than non-smokers with a similar HF burden[35]. This finding should be
interpreted with caution as the proportion of smokers in our study was small. We also did not
collect data on smoking cessation during the trial, and do not know if these women’s symp-
toms improved because they stopped smoking.
Henry Beecher reported that about 30% of patients responded positively to a placebo treat-
ment. However, in doing so, he failed to distinguish the placebo response from other con-
founding factors, therefore over-inflating the perceived power of the placebo[6]. This error has
persisted, and today the placebo response is frequently confused with the overall improvement
that occurs in a placebo control group, which is a composite of the psychobiological placebo
response and other reasons for clinical improvement such as regression to the mean.
The placebo response is a distinct psychobiological response seen when a placebo is admin-
istered, mediated by opioidergic and dopaminergic pathways and modified by psychosocial
context[36]. This response can be reversed by the opioid antagonist naloxone and can also
have non-opioidergic effects[6]. It is not equivalent to the overall response seen in control
groups, and should be carefully distinguished from other factors that can induce a clinical
response. Expectancy and classical conditioning are the principal mechanisms of the placebo
response, however in this study we failed to find an association between expectancy and treat-
ment outcome. This suggests that the improvement in HFs is mediated by factors other than
the physiological placebo response.
Non-placebo improvements can be seen in active, control and placebo groups. Here,
improvements in both groups may have been due to response bias. Research participants can
become attached to the research team and committed to success of the trial, which may predis-
pose them to report improvements in symptoms[37]. Alternatively, participants may have felt
compelled to rate their expectations higher than they actually were.
Another likely explanation for clinical improvement in our study may be the frequent ther-
apist interaction that is inseparable from the act of receiving acupuncture needling. Although
earlier studies suggested that empathic consultation styles predicted treatment outcomes in
acupuncture consultations[38, 39], more recent studies have not replicated this finding[26].
However, qualitative research by Paterson and colleagues indicate that patients attending for
acupuncture consultations value the “talking, listening and practitioners’ attention to them as
an individual”[40] and practitioner characteristics of being “considerate, respectful, caring,
kind, understanding, professional, helpful, reassuring and supportive”. Also, patients in Pater-
son’s study valued the interactions with clinic staff and the friendly atmosphere of acupuncture
clinics. In particular, practitioner empathy has been linked to patient enablement[38], which
suggests that participants in our study may have developed new ways to cope with their
Expectancy after the first treatment and acupuncture
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symptoms and new self-care strategies, as a result of interacting with an empathic practitioner.
This is supported by findings from antidepressant trials reporting markedly improved out-
comes when participants had a greater number of treatment visits[41] and findings from a
Cochrane review on placebo interventions which found larger clinical improvements with
physical placebos compared with placebo pills, particularly with those that required the place-
bos to be administered by a therapist[42, 43]. In a mixed-methods study on acupuncture for
dysmenorrhoea, participants described a feeling of partnership with their practitioners, valida-
tion of their symptoms, and a sense of hope arising from the acupuncture consultations, which
contributed to their overall improvement[44]. Future research may need to study non-nee-
dling effects of acupuncture including assessment of the quality of the therapeutic relationship,
and level of practitioner empathy.
Another likely reason for clinical improvement is the physiological effect of sham needling.
Sham acupuncture blinds participants and controls for both expectations from receiving acu-
puncture and for other effects not associated with needling, including seeing a therapist. This
minimises performance and detection bias, particularly if outcomes are self-reported[43].
However, light stimulation of the skin can activate descending pain modulation pathways, par-
ticularly with repeated stimulation[45]. Sham acupuncture is widely recognised as a “non-
inert” comparator, and has been criticised as an inadequate control method for acupuncture
[46, 47]. The effectiveness of “placebo devices” for acupuncture has been comprehensively
reviewed recently[48] and although the Park Sham Device used in our study appears to be
superior to other non-invasive devices, none of the currently available sham control methods
are considered inert and certainly none are equivalent to placebo.
Strengths of the main acupuncture study include a broad recruitment strategy, successful
blinding of participants, high retention rate, and approximately equal proportions of partici-
pants with previous acupuncture experience and no previous acupuncture experience. Addi-
tionally, although this was a secondary analysis, it was considered a priori[19] therefore adding
to the rigour of our analysis.
Some limitations must be considered when interpreting our findings. First, our primary
aim was to assess the efficacy of acupuncture for hot flashes, and not to evaluate the impact of
expectancy on treatment outcome. Second, we only measured expectations immediately after
the first treatment and it is possible that expectations change over time especially in response
to a perceived improvement in symptoms. Third, 13% of women did not return surveys on
expectancy, therefore the impact of expectations in these women is unknown; as well as this,
we had a number of missing responses to the other variables. Also, although we used a vali-
dated and widely-used expectancy scale, treatment expectancy is difficult to measure. For par-
ticipants to respond accurately they must interpret the question correctly, be aware of their
own expectations and understand the rating scale of the question. Also, we modified the CEQ
by using the 9-point Likert scale instead of a scale from 0–100% for the expectancy questions,
although we think the impact on our findings would be minimal. Fourth, we did not include a
no-treatment control group, and do not have data on the true inert placebo effect in our study,
that is, given sham acupuncture appears not to be equal to placebo.
Finally, expectancy is but one of the psychological mechanisms contributing to the placebo
response, albeit a key mechanism. Other mechanisms contributing to the placebo response
include classical conditioning, learning, memory, motivation, somatic focus, anxiety reduction
and meaning[6] and it is possible that some of these may have played a role in treatment out-
come. In a qualitative study of participants of a sham-controlled trial of acupuncture for irrita-
ble bowel syndrome, Kaptchuk and colleagues found that the experiences of participants were
complex and idiosyncratic, concluding that the placebo response in a randomized placebo-
controlled trial context is not a simple and linear construct[49].
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Conclusions
Findings from this post hoc analysis of our large randomized clinical trial of acupuncture for
menopausal hot flashes demonstrate that there was no evidence for an association between
expectancy measured immediately after the first treatment, and treatment outcome. Our find-
ings refute the assertion that the effects of acupuncture are driven by patient expectations.
Rather, the non-specific effects of acupuncture may relate more to other factors that can influ-
ence response to comparators or placebos in clinical research including therapist attention and
increased sense of enablement.
The role of sham controls in acupuncture trials should be revisited and suitable compara-
tors for acupuncture should be considered in future research, such as comparing acupuncture
to equivalent attention interventions. We also found that being a regular smoker was associ-
ated with a large clinical improvement; the reasons for this are unclear but should be explored
further.
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